Biggest changeConsolidated EBITDA and Adjusted EBITDA from continuing operations are as follows: Year Ended December 31, ($ in thousands) 2023 2022 Consolidated Net (loss) income from continuing operations $ (34,151) $ 17,578 Adjustments: Interest expense 4,238 2,742 Income taxes (6,924) (5,568) Depreciation 6,161 6,421 Amortization 1,505 1,853 EBITDA (29,171) 23,026 Acquisition costs and other 856 1,104 Shelf registration costs — 12 Goodwill impairment 11,389 — Gain on lease modification — (2) Stock-based compensation 594 962 Non-cash lease expense 242 414 Retention expense 26 — Restructuring and severance costs 130 74 Adjusted EBITDA $ (15,934) $ 25,590 % sales (8.2) % 9.8 % 18 Table of Contents Tubular Products EBITDA and Adjusted EBITDA from continuing operations are as follows: Year Ended December 31, ($ in thousands) 2023 2022 Tubular Products Net (loss) income from continuing operations $ (11,210) $ 22,182 Adjustments: Depreciation 2,274 2,500 Amortization 871 951 EBITDA (8,065) 25,633 Stock-based compensation 58 46 Non-cash lease expense 118 — Retention expense 8 — Restructuring and severance costs 84 20 Tubular Products Adjusted EBITDA $ (7,797) $ 25,699 % of segment sales (7.1) % 16.7 % Specialty Chemicals EBITDA and Adjusted EBITDA are as follows: Year Ended December 31, ($ in thousands) 2023 2022 Specialty Chemicals Net (loss) income $ (12,619) $ 6,935 Adjustments: Interest expense 74 36 Depreciation 3,798 3,846 Amortization 634 903 EBITDA (8,113) 11,720 Acquisition costs and other 12 — Goodwill impairment 11,389 — Stock-based compensation 8 41 Non-cash lease expense 88 2 Restructuring and severance costs 40 8 Specialty Chemicals Adjusted EBITDA $ 3,424 $ 11,771 % of segment sales 4.1 % 10.9 % 19 Table of Contents Liquidity and Capital Resources We closely manage our liquidity and capital resources.
Biggest changeConsolidated EBITDA and Adjusted EBITDA from continuing operations are as follows: Year Ended December 31, ($ in thousands) 2024 2023 Consolidated Net loss from continuing operations $ (11,225) $ (34,151) Adjustments: Interest expense 418 4,238 Income taxes 6,159 (6,924) Depreciation 5,936 6,161 Amortization 1,487 1,505 EBITDA 2,775 (29,171) Acquisition costs and other 692 856 Goodwill impairment — 11,389 Gain on lease modification (67) — Stock-based compensation 204 594 Non-cash lease expense 198 242 Retention expense 3 26 Restructuring and severance costs 208 130 Adjusted EBITDA $ 4,013 $ (15,934) % sales 2.3 % (8.2) % 17 Table of Contents Specialty Chemicals EBITDA and Adjusted EBITDA are as follows: Year Ended December 31, ($ in thousands) 2024 2023 Specialty Chemicals Net income (loss) $ 1,093 $ (12,619) Adjustments: Interest expense 75 74 Depreciation 3,809 3,798 Amortization 695 634 EBITDA 5,672 (8,113) Acquisition costs and other 477 12 Goodwill impairment — 11,389 Stock-based compensation 7 8 Non-cash lease expense 66 88 Restructuring and severance costs 110 40 Specialty Chemicals Adjusted EBITDA $ 6,332 $ 3,424 % of segment sales 7.8 % 4.1 % Tubular Products EBITDA and Adjusted EBITDA from continuing operations are as follows: Year Ended December 31, ($ in thousands) 2024 2023 Tubular Products Net income (loss) from continuing operations $ 2,649 $ (11,210) Adjustments: Interest expense 1 — Depreciation 2,052 2,274 Amortization 792 871 EBITDA 5,494 (8,065) Acquisition costs and other 30 — Stock-based compensation 10 58 Non-cash lease expense 88 118 Retention expense — 8 Restructuring and severance costs 30 84 Tubular Products Adjusted EBITDA $ 5,652 $ (7,797) % of segment sales 5.8 % (7.1) % 18 Table of Contents Liquidity and Capital Resources We closely manage our liquidity and capital resources.
Divestiture of Specialty Pipe & Tube, Inc. On December 22, 2023, the Company and its wholly-owned subsidiary Specialty Pipe & Tube, Inc. (“SPT”) entered into an Asset Purchase Agreement pursuant to which Ascent and SPT sold substantially all of the assets primarily related to SPT to Specialty Pipe & Tube Operations, LLC, a Delaware limited liability company.
On December 22, 2023, the Company and its wholly-owned subsidiary Specialty Pipe & Tube, Inc. (“SPT”) entered into an Asset Purchase Agreement pursuant to which Ascent and SPT sold substantially all of the assets primarily related to SPT to Specialty Pipe & Tube Operations, LLC, a Delaware limited liability company.
Profitability Ratio: • Return on average equity ("ROAE") = net (loss) income divided by the trailing 12-month average of equity. The ROAE will be determined by the Company using generally accepted accounting principles, consistently applied.
The current ratio will be determined by the Company using generally accepted accounting principles, consistently applied. Profitability Ratio: • Return on average equity ("ROAE") = net (loss) income divided by the trailing 12-month average of equity. The ROAE will be determined by the Company using generally accepted accounting principles, consistently applied.
Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP. 17 Table of Contents EBITDA and Adjusted EBITDA We define "EBITDA" as earnings before interest, income taxes, depreciation and amortization.
Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP. 16 Table of Contents EBITDA and Adjusted EBITDA We define "EBITDA" as earnings before interest, income taxes, depreciation and amortization.
However, it is possible that actual results could differ from recorded reserves. For instance, a 10% change in the amount of products considered obsolete would have decreased net earnings by $0.6 million for 2023. A 10% change in the estimated shrinkage rate would not have had a material impact on net earnings for 2023.
However, it is possible that actual results could differ from recorded reserves. For instance, a 10% change in the amount of products considered obsolete would have decreased net earnings by $0.6 million for 2024. A 10% change in the estimated shrinkage rate would not have had a material impact on net earnings for 2024.
The decrease in cash used in investing activities for the full-year 2023 compared to cash used in investing activities for the full-year 2022 was primarily driven by a decrease in capital expenditures in the current year over the prior year. Financing Activities Net cash used in financing activities primarily consist of transactions related to our long-term debt.
The decrease in cash used in investing activities for the full-year 2024 compared to cash used in investing activities for the full-year 2023 was primarily driven by a decrease in capital expenditures in the current year over the prior year. Financing Activities Net cash used in financing activities primarily consist of transactions related to our long-term debt.
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations This discussion and analysis summarizes the significant factors affecting our consolidated operating results, financial condition, liquidity, and capital resources during the fiscal years ended December 31, 2023 and 2022.
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations This discussion and analysis summarizes the significant factors affecting our consolidated operating results, financial condition, liquidity, and capital resources during the fiscal years ended December 31, 2024 and 2023.
Our existing cash, cash equivalents, and credit facilities balances may fluctuate during 2024. Cash from operations could also be affected by various risks and uncertainties detailed in Item 1A - Risk Factors of this report.
Our existing cash, cash equivalents, and credit facilities balances may fluctuate during 2025. Cash from operations could also be affected by various risks and uncertainties detailed in Item 1A - Risk Factors of this report.
In this process, certain relevant criteria are evaluated including: the amount of income or loss in prior years, the existence of deferred tax 24 Table of Contents liabilities that can be used to absorb deferred tax assets, the taxable income in prior carryback years that can be used to absorb net operating losses and credit carry backs, future expected taxable income and prudent and feasible tax planning strategies.
In this process, certain relevant criteria are evaluated including: the amount of income or loss in prior years, the existence of deferred tax liabilities that can be used to absorb deferred tax assets, the taxable income in prior carryback years that can be used to absorb net operating losses and credit carry backs, future expected taxable income and prudent and feasible tax planning strategies.
If recovery is not more likely than not (a likelihood of less than 50 percent), the provision for taxes must be increased by recording a reserve in the form of a valuation allowance for the deferred tax assets that are estimated not to ultimately be recoverable.
If recovery is not expected to exceed a more likely than not (a likelihood of less than 50 percent) threshold, the provision for taxes must be increased by recording a reserve in the form of a valuation allowance for the deferred tax assets that are estimated not to ultimately be recoverable.
Our inventory reserve for estimated shrinkage was $0.5 million as of December 31, 2023. Judgments and uncertainties involved in the estimate We do not believe that our inventories are subject to significant risk of obsolescence in the near term and we have the ability to adjust purchasing practices based on anticipated sales trends and general economic conditions.
Our inventory reserve for estimated shrinkage was $0.3 million as of December 31, 2024. Judgments and uncertainties involved in the estimate We do not believe that our inventories are subject to significant risk of obsolescence in the near term and we have the ability to adjust purchasing practices based on anticipated sales trends and general economic conditions.
These items include: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, shelf registration costs, loss on extinguishment of debt, earn-out adjustments, retention costs and restructuring and severance costs from net (loss) income.
These items include: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, shelf registration costs, loss on extinguishment of debt, retention costs and restructuring and severance costs from net (loss) income.
In 2023 and 2022, no dividends were declared or paid by the Company. 21 Table of Contents Other Financial Measures Below are additional financial measures that we believe are important in understanding the Company's liquidity position from year to year. The metrics are defined as: Liquidity Measure: • Current ratio = current asset divided by current liabilities.
In 2024 and 2023, no dividends were declared or paid by the Company. 20 Table of Contents Other Financial Measures Below are additional financial measures that we believe are important in understanding the Company's liquidity position from year to year. The metrics are defined as: Liquidity Measure: • Current ratio = current asset divided by current liabilities.
The Company has no off-balance sheet arrangements that are reasonably likely to have a material current or future effect on the Company's financial position, revenues, results of operations, liquidity, or capital expenditures. We expect capital spending in fiscal 2024 to be as much as $6.5 million.
The Company has no off-balance sheet arrangements that are reasonably likely to have a material current or future effect on the Company's financial position, revenues, results of operations, liquidity, or capital expenditures. We expect capital spending in fiscal 2025 to be as much as $7.6 million.
Unless otherwise noted, all references herein for the years 2023 and 2022 represent the fiscal years ended December 31, 2023 and 2022, respectively.
Unless otherwise noted, all references herein for the years 2024 and 2023 represent the fiscal years ended December 31, 2024 and 2023, respectively.
Operating and finance lease obligations were $32.5 million, with $1.4 million payable within 12 months. See Note 7 for further detail of our lease obligations and the timing of expected future payments.
Operating and finance lease obligations were $32.9 million, with $1.8 million payable within 12 months. See Note 7 for further detail of our lease obligations and the timing of expected future payments.
We have provided valuation allowances as of December 31, 2023, aggregating to $1.6 million, net of federal benefit, against certain state and local net operating loss carryforwards and other deferred tax assets. As of December 31, 2023, the Company has no liability for unrecognized income tax benefits.
We have provided valuation allowances as of December 31, 2024, aggregating to $9.1 million, net of federal benefit, against our federal deferred tax assets as well as certain state and local net operating loss carryforwards and other deferred tax assets. As of December 31, 2024, the Company has no liability for unrecognized income tax benefits.
We also record an inventory reserve for the estimated shrinkage (quantity losses) between physical inventories. This reserve is based upon the most recent physical inventory results. During 2023, the inventory shrink reserve had a $0.4 million increase in response to estimated shrinkage rates based on results from previous physical inventories.
We also record an inventory reserve for the estimated shrinkage (quantity losses) between physical inventories. This reserve is based upon the most recent physical inventory results. During 2024, the inventory shrink reserve had a $0.3 million decrease in response to estimated shrinkage rates based on results from previous physical inventories.
Results of these additional financial measures are as follows: Year ended December 31, 2023 2022 Current ratio 3.7 4.6 Debt to capital —% 49% Return on average equity (38.6)% 29.7% Material Cash Requirements from Contractual and Other Obligations As of December 31, 2023, our material cash requirements for our known contractual and other obligations were as follows: • Operating and Finance Leases - The Company enters into various lease agreements for real estate and manufacturing equipment used in the normal course of business.
Results of these additional financial measures are as follows: Year ended December 31, 2024 2023 Current ratio 3.8 3.7 Return on average equity (11.3)% (38.6)% Material Cash Requirements from Contractual and Other Obligations As of December 31, 2024, our material cash requirements for our known contractual and other obligations were as follows: • Operating and Finance Leases - The Company enters into various lease agreements for real estate and manufacturing equipment used in the normal course of business.
Inventory increased operating cash flows for the year ended December 31, 2023 by approximately $12.2 million compared to a decrease of approximately $13.7 million for 2022, while accounts payable increased operating cash flows by approximately $1.6 million for the year ended December 31, 2023 compared to an decrease of approximately $6.3 million for the year ended December 31, 2022.
Inventory increased operating cash flows for the year ended December 31, 2024 by approximately $11.6 million compared to a decrease of approximately $12.2 million for 2023, while accounts payable decreased operating cash flows by approximately $3.6 million for the year ended December 31, 2024 compared to an increase of approximately $1.6 million for the year ended December 31, 2023.
There is no guarantee as to the exact number of shares that will be repurchased by the Company, and the Company may discontinue purchases at any time that management determines additional purchases are not warranted. As of December 31, 2023, the Company has 536,871 shares of its share repurchase authorization remaining.
There is no guarantee as to the exact number of shares that will be repurchased by the Company, and the Company may discontinue purchases at any time that management determines additional purchases are not warranted. As of December 31, 2024, the Company had 435,608 shares of its previous share repurchase authorization remaining.
Sources of Liquidity Funds generated by operating activities supplemented by our available cash and cash equivalents and our credit facilities are our most significant sources of liquidity. As of December 31, 2023, we held $1.9 million of cash and cash equivalents, as well as $61.8 million of remaining available capacity on our revolving line of credit.
Sources of Liquidity Funds generated by operating activities supplemented by our available cash and cash equivalents and our credit facilities are our most significant sources of liquidity. As of December 31, 2024, we held $16.1 million of cash and cash equivalents, as well as $47.4 million of remaining available capacity on our revolving line of credit.
We record an obsolete inventory reserve for identified aged inventory items with slow or no sales activity for finished goods or slow or no usage for raw materials for a certain period of time.
This would indicate that an adjustment would be required. We record an obsolete inventory reserve for identified aged inventory items with slow or no sales activity for finished goods or slow or no usage for raw materials for a certain period of time.
Shares repurchased for the year ended December 31, 2023 and 2022 were as follows: Year ended December 31, 2023 2022 Number of shares repurchased 143,108 110,404 Average price per share $ 8.97 $ 12.16 Total cost of shares repurchased $ 1,287,416 $ 1,345,540 At the end of each fiscal year, the Board reviews the financial performance and capital needed to support future growth to determine the amount of cash dividend, if any, which is appropriate.
Shares repurchased for the year ended December 31, 2024 and 2023 were as follows: Year ended December 31, 2024 2023 Number of shares repurchased 101,263 143,108 Average price per share $ 10.21 $ 8.97 Total cost of shares repurchased $ 1,037,346 $ 1,287,416 At the end of each fiscal year, the Board reviews the financial performance and capital needed to support future growth to determine the amount of cash dividend, if any, which is appropriate.
For those inventory items, a reserve is established for a percentage of the inventory cost less any estimated scrap proceed and is based on our current knowledge with respect to inventory levels, sales trends and historical experience. During 2023, our reserve increased approximately $2.8 million to $5.6 million as of December 31, 2023.
For those inventory items, a reserve is established for a percentage of the inventory cost less any estimated scrap proceeds and is based on our current knowledge with respect to inventory levels, sales trends and historical experience. During 2024, our reserve decreased approximately $0.1 million to $5.5 million as of December 31, 2024.
The Company has no debt outstanding as of December 31, 2023. The Company's effective tax rate for 2023 was less than the U.S. statutory rate of 21% primarily driven by tax benefits associated with non-deductible goodwill impairment.
The Company's effective tax rate for 2023 was less than the U.S. statutory rate of 21% primarily driven by tax benefits associated with non-deductible goodwill impairment.
Cash Flows Cash flows from continuing operations were as follows: Year ended December 31, (in thousands) 2023 2022 Total cash provided by (used in): Operating activities 6,644 (5,262) Investing activities (2,885) (3,295) Financing activities (73,169) (374) Net decrease in cash and cash equivalents $ (69,410) $ (8,931) Operating Activities The increase in cash provided by operating activities for the year ended December 31, 2023 compared to cash used in operating activities in the year ended December 31, 2022 was primarily driven by changes in working capital.
Cash Flows Cash flows from continuing operations were as follows: Year ended December 31, (in thousands) 2024 2023 Total cash provided by (used in): Operating activities 17,007 6,644 Investing activities (1,892) (2,885) Financing activities (1,329) (73,169) Net increase (decrease) in cash and cash equivalents $ 13,786 $ (69,410) Operating Activities The increase in cash provided by operating activities for the year ended December 31, 2024 compared to cash used in operating activities in the year ended December 31, 2023 was primarily driven by changes in working capital.
Accounts receivable increased operating cash flow by approximately $6.8 million compared to a decrease of $0.3 million driven by lower sales in the current year partially offset by slightly higher days sales outstanding.
Accounts receivable increased operating cash flow by approximately $2.8 million compared to an increase of $6.8 million driven by lower sales in the current year partially offset by lower days sales outstanding.
The changes in SG&A expense were primarily driven by decreases in salaries, wages and benefits and lower travel expense partially offset by increases in taxes and licenses expense. Operating loss for the full-year 2023 totaled $11.2 million compared to operating income of $22.2 million for the full-year 2022.
The changes in SG&A expense were primarily driven by increases in corporate allocation partially offset by decreases in salaries, wages and benefits, taxes and license fees and professional fees. Operating income for the full-year 2024 totaled $2.6 million compared to an operating loss of $11.2 million for the full-year 2023.
The changes in SG&A expense were primarily driven by increases in salaries, wages and benefits and professional fees partially offset by lower incentive bonus and amortization expense. Operating loss for the full-year 2023 totaled $12.6 million compared to operating income of $7.0 million for the full-year 2022.
The changes in SG&A expense were primarily driven by increases in corporate allocation, incentive bonus expense and professional fees, partially offset by decreases in salaries, wages and benefits and taxes and license fees. Operating income for the full-year 2024 totaled $1.2 million compared to an operating loss of $12.6 million for the full-year 2023.
The Credit Facility Amendment also reduced the maximum revolving loan commitment under the credit facility from $105 million to $80 million, and increased the interest rate for the credit facility from SOFR plus an interest rate margin of between 1.60% and 1.70% to SOFR plus an interest rate margin of between 1.85% and 2.10%, depending on average availability under the credit facility and the Company’s consolidated fixed charge coverage ratio.
The Credit Facility Amendment also increased the interest rate for the credit facility from SOFR plus an interest rate margin of between 1.85% and 2.10% to SOFR plus an interest rate margin of between 1.85% and 2.35%, depending on average availability under the credit facility and Ascent’s consolidated fixed charge coverage ratio.
The increase in operating cash flows from inventory is primarily due to lower inventory turns year over year while the increase in accounts payable is primarily driven by a slight increase in days payables outstanding.
The increase in operating cash flows from inventory is primarily due to lower average inventory and higher inventory turns year over year while the decrease in accounts payable is primarily driven by a decreases in days payables outstanding within our Specialty Chemicals segment.
The decrease in net sales was primarily driven by a 17.3% decrease in pounds shipped and a 4.3% decrease in average selling prices. SG&A expense increased by $0.1 million, or 1.1%, to $7.0 million in 2023 compared to $6.9 million in 2022. SG&A as a percentage of sales increased to 8.3% in 2023 from 6.4% in 2022.
The decrease in net sales was primarily driven by a 16.8% decrease in average selling prices offset by a 5.5% increase in pounds shipped. SG&A expense increased $1.2 million, or 16.0%, for the full-year 2024 when compared to 2023. SG&A as a percentage of sales was 9.0% of sales for 2024 and 6.9% of sales for 2023.
The share repurchase program allows for repurchase of up to 790,383 shares of the Company's outstanding common stock and expires on February 17, 2025. The shares will be purchased from time to time at prevailing market prices, through open market or privately negotiated transactions, depending on market conditions.
On February 17, 2025, the Board of Directors authorized a new share repurchase program allowing for repurchase of up to 1.0 million shares of the Company's outstanding common stock over 24 months. The shares will be purchased from time to time at prevailing market prices, through open market or privately negotiated transactions, depending on market conditions.
This strategic decision is part of the Company’s ongoing efforts to consolidate manufacturing to drive an increased focus on its core operations and to improve profitability while driving operational efficiencies.
This strategic decision is part of the Company’s ongoing efforts to consolidate manufacturing to drive an increased focus on its core operations and to improve profitability while driving operational efficiencies. Munhall results are included within discontinued operations in all periods presented. Divestiture of Specialty Pipe & Tube, Inc.
Reference should be made to Note 13 to the consolidated financial statements included in Item 8 of this Form 10-K. 2023 2022 (in thousands) Amount % Amount % Net sales $ 83,616 100.0 % $ 107,542 100.0 % Cost of goods sold 77,807 93.1 % 93,680 87.1 % Gross profit 5,809 6.9 % 13,862 12.9 % Selling, general and administrative expense 6,966 8.3 % 6,891 6.4 % Acquisition costs and other 12 — % — — % Goodwill impairment 11,389 13.6 % — — % Operating (loss) income $ (12,558) (15.0) % $ 6,971 6.5 % Comparison of 2023 to 2022 - Corporate Corporate expenses decreased $1.1 million to $12.9 million in 2023 down from $13.9 million in 2022.
Reference should be made to Note 13 to the consolidated financial statements included in Item 8 of this Form 10-K. 2024 2023 (in thousands) Amount % Amount % Net sales $ 80,764 100.0 % $ 83,616 100.0 % Cost of goods sold 69,574 86.1 % 77,807 93.1 % Gross profit 11,190 13.9 % 5,809 6.9 % Selling, general and administrative expense 9,546 11.8 % 6,966 8.3 % Acquisition costs and other 477 0.6 % 12 — % Goodwill impairment — — % 11,389 13.6 % Operating income (loss) $ 1,167 1.4 % $ (12,558) (15.0) % Table of Contents Comparison of 2024 to 2023 - Tubular Products Net sales for the Tubular Products segment totaled $97.1 million for the full year of 2024, a decrease of 11.3% compared to the full-year 2023.
Fair value determinations involve significant assumptions about highly subjective variables, including future cash flows, discount rates, and expected business performance. There are also different valuation models and inputs for each component, the selection of which requires considerable judgment. Our estimates and assumptions may be based, in part, on the availability of listed market prices or other transparent market data.
There are also different valuation models and inputs for each component, the selection of which requires considerable judgment. Our estimates and assumptions may be based, in part, on the availability of listed 21 Table of Contents market prices or other transparent market data.
Judgments and uncertainties involved in the estimate We assess on a tax jurisdictional basis the likelihood that our deferred tax assets can be recovered.
We record interest and penalties, if any, related to uncertain tax positions as a component of income tax expense. Judgments and uncertainties involved in the estimate We assess on a tax jurisdictional basis the likelihood that our deferred tax assets can be recovered.
As of December 31, 2023, the Company had $61.8 million of remaining availability under its credit facility. The Facility contains covenants requiring the maintenance of a minimum consolidated fixed charge coverage ratio if excess availability falls below the greater of (i) $7.5 million and (ii) 10% of the revolving credit facility (currently $8.0 million).
The Facility contains covenants requiring the maintenance of a minimum consolidated fixed charge coverage ratio if excess availability falls below the greater of (i) $6.0 million and (ii) 15% of the revolving credit facility (currently $9.0 million). As of December 31, 2024, the Company was in compliance with all financial debt covenants.
Under this method, the total consideration transferred to consummate the business combination is allocated to the identifiable tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the closing date of the transaction. 22 Table of Contents Judgments and uncertainties involved in the estimate The acquisition method of accounting requires extensive use of estimates and judgments to allocate the consideration transferred to the identifiable tangible and intangible assets acquired, if any, and liabilities assumed.
Business Combinations Description Business combinations are accounted for using the acquisition method of accounting in accordance with GAAP. Under this method, the total consideration transferred to consummate the business combination is allocated to the identifiable tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the closing date of the transaction.
Reference should be made to Note 13 to the consolidated financial statements included in Item 8 of this Form 10-K. 2023 2022 (in thousands) Amount % Amount % Net sales $ 109,513 100.0 % $ 154,040 100.0 % Cost of goods sold 113,187 103.4 % 123,726 80.3 % Gross profit (3,674) (3.4) % 30,314 19.7 % Selling, general and administrative expense 7,536 6.9 % 8,132 5.3 % Operating (loss) income $ (11,210) (10.2) % $ 22,182 14.4 % Comparison of 2023 to 2022 – Specialty Chemicals Net sales for the Specialty Chemicals segment decreased 22.2%, or $23.9 million, to $83.6 million for 2023 compared to $107.5 million in 2022.
Reference should be made to Note 13 to the consolidated financial statements included in Item 8 of this Form 10-K. 2024 2023 (in thousands) Amount % Amount % Net sales $ 97,108 100.0 % $ 109,513 100.0 % Cost of goods sold 85,686 88.2 % 113,187 103.4 % Gross profit 11,422 11.8 % (3,674) (3.4) % Selling, general and administrative expense 8,743 9.0 % 7,536 6.9 % Acquisition costs and other 30 0.1 % — — % Operating income (loss) from continuing operations $ 2,649 2.7 % $ (11,210) (10.2) % Comparison of 2024 to 2023 - Corporate Corporate expenses decreased $4.1 million to $8.8 million in 2024 down from $12.9 million in 2023.
At the end of each quarter, all facilities review recent sales reports to identify sales price trends that would indicate products or product lines that are being sold below our cost. This would indicate that an adjustment would be required.
Inventory Description Inventory is stated at the lower of cost or net realizable value. Cost is determined by either specific identification or weighted average methods. At the end of each quarter, all facilities review recent sales reports to identify sales price trends that would indicate products or product lines that are being sold below our cost.
The increase in net cash used in financing activities for the full-year 2023 compared to the full-year 2022 was primarily due to the repayment of the Company's asset backed line of credit and delayed draw term loan in the fourth quarter of 2023 driven by the sale of substantially all of the assets of SPT. 20 Table of Contents Short-term Debt The Company has a note payable in the amount of $0.9 million with an annual interest rate of 3.70% maturing April 1, 2024, associated with the financing of the Company's insurance premium in the current year.
The decrease in net cash used in financing activities for the full-year 2024 compared to the full-year 2023 was primarily due to the repayment of the 19 Table of Contents Company's asset backed line of credit and delayed draw term loan in the fourth quarter of 2023 driven by the sale of substantially all of the assets of SPT.
We recognize net tax benefits under the recognition and measurement criteria of FASB ASC Topic 740, Income Taxes, which prescribes requirements and other guidance for financial statement recognition and measurement of positions taken or expected to be taken on tax returns. We record interest and penalties, if any, related to uncertain tax positions as a component of income tax expense.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. 22 Table of Contents We recognize net tax benefits under the recognition and measurement criteria of FASB ASC Topic 740, Income Taxes, which prescribes requirements and other guidance for financial statement recognition and measurement of positions taken or expected to be taken on tax returns.
The changes in SG&A expense were primarily driven by: • decrease in incentive bonus driven by lower attainment of performance goals in the current year over the prior year; • decrease in repair and maintenance expenses; and, 15 Table of Contents • decreases in other expenses primarily driven by decreases in salaries, wages and benefits, share-based compensation, amortization expense, bad debt expense and utilities The full-year decreases were partially offset by: • Increases in professional fees; and, • Increases and taxes and licenses.
The changes in SG&A expense were primarily driven by: • decreases in salaries, wages and benefits driven by lower headcount in the current year; • decreases in taxes and licenses; and, • decreases in other expenses primarily driven by decreases in share-based compensation expense The full-year decreases were partially offset by: • increases in incentive bonus driven by higher attainment of performance goals in the current year over the prior year; • increases in professional fees driven by increased IT and legal expenses in the current year Operating loss from continuing operations for the full-year 2024 improved to $5.1 million compared to an operating loss of $37.4 million for the full-year 2023.
Comparison of 2023 to 2022 - Tubular Products Net sales for the Tubular Products segment totaled $109.5 million for the full year of 2023, a decrease of 28.9% compared to the full-year 2022. The decrease in net sales was primarily driven by a 21.4% decrease in pounds shipped and a 9.2% decrease in average selling price.
Comparison of 2024 to 2023 – Specialty Chemicals Net sales for the Specialty Chemicals segment decreased 3.4%, or $2.9 million, to $80.8 million for 2024 compared to $83.6 million in 2023. The decrease in net sales was primarily driven by a 3.4% decrease in pounds shipped and a 2.6% decrease in average selling prices.
This discussion and analysis is presented in five sections: • Executive Overview • Results of Operations and Non-GAAP Financial Measures • Liquidity and Capital Resources • Material Cash Requirements from Contractual and Other Obligations • Critical Accounting Policies and Estimates Executive Overview There have been a number of strategic changes that have occurred throughout 2023, including the permanent cessation of operations and closure of the Munhall facility and the sale of substantially all of assets of Specialty Pipe & Tube, Inc.
This discussion and analysis is presented in five sections: • Executive Overview • Results of Operations and Non-GAAP Financial Measures • Liquidity and Capital Resources • Material Cash Requirements from Contractual and Other Obligations • Critical Accounting Policies and Estimates Executive Overview Ascent Industries Co. is a diverse industrials company focused on the production of specialty chemicals and stainless steel pipe and tube.
In addition to the working capital changes, changes in income taxes increased cash flows by approximately $3.1 million compared to cash used in operations of approximately $7.9 million in 2022. This was driven by the receipt of a cash refund from the Company's 2022 tax return.
In addition to the working capital changes, changes in deferred income taxes increased cash flows by approximately $6.2 million compared to cash used in operations of approximately $6.9 million in 2023.
The consideration for the transaction was approximately $55 million of cash proceeds subject to certain closing adjustments. The transaction closed on December 22, 2023.
The consideration for the transaction was approximately $55 million of cash proceeds subject to certain closing adjustments. The transaction closed on December 22, 2023. As result of the sale, SPT results of operations are classified under discontinued operations for all periods presented. Prior to the divestiture, SPT was reported under the Company's Tubular Products segment.
Investing Activities Net cash used in investing activities primarily consists of transactions related to capital expenditures, proceeds from the disposal of property, plant and equipment and acquisitions.
This was primarily due to discrete tax charges associated with the recording of a valuation allowance on cumulative U.S. federal and state tax assets in the third quarter of 2024. Investing Activities Net cash used in investing activities primarily consists of transactions related to capital expenditures, proceeds from the disposal of property, plant and equipment and acquisitions.
The payment of cash dividends is also subject to customary legal and contractual restrictions. Our capital allocation strategy is to first fund operations and investments in growth and then return excess cash over time to shareholders through share repurchases and dividends.
Our capital allocation strategy is to first fund operations and investments in growth and then return excess cash over time to shareholders through share repurchases and dividends. The Company's previous share repurchase program allowed for repurchase of up to 790,383 shares of the Company's outstanding common stock and expired on February 17, 2025.
During the year, we also repurchased 143,108 shares for $1.3 million through our share repurchase program as part of our continued efforts to create sustainable value for our shareholders. Munhall Closure During the second quarter of 2023, the Board of Directors of the Company made the decision to permanently cease operations at Munhall effective on or around August 31, 2023.
Munhall Closure During the second quarter of 2023, the Board of Directors of the Company made the decision to permanently cease operations at Munhall effective on or around August 31, 2023.
SG&A expense decreased $0.6 million, or 7.3%, for the full-year 2023 when compared to 2022. SG&A as a percentage of sales was 6.9% of sales for 2023 and 5.3% of sales for 2022.
SG&A expense increased by $2.6 million, or 37.0%, to $9.5 million in 2024 compared to $7.0 million in 2023. SG&A as a percentage of sales increased to 11.8% in 2024 from 8.3% in 2023.
The Company's effective tax rate for 2022 was less than the U.S. statutory rate of 21% primarily driven by tax benefits associated with the closure of Palmer and the release of valuation allowances on certain deferred tax assets, partially offset by state taxes.
The Company's effective tax rate for 2024 was less than the U.S. statutory rate of 21% primarily due to discrete tax charges associated with recording a valuation allowance on cumulative US Federal and state deferred tax assets.
As of December 31, 2023, the outstanding balance was $0.4 million. Long-term Debt During the fourth quarter of 2023, the Company entered into a Limited Consent, Second Amendment to Credit Agreement and Omnibus Amendment to Loan Documents with BMO Bank N.A. and the other lenders under the Company’s credit facility (the “Credit Facility Amendment”).
Long-term Debt On November 6, 2024, Ascent entered into a Limited Consent, Third Amendment to Credit Agreement to Loan Documents with BMO Bank N.A. under Ascent’s credit facility (the “Credit Facility Amendment”).
The operating loss increase for the full-year 2023 was primarily driven by aforementioned decreases in pounds shipped and lower selling price as well as higher material costs. The following table summarizes operating results for the two years indicated.
The operating income increase for the full-year 2024 was primarily driven by increases in gross profit partially offset by the aforementioned increases in SG&A expenses. The following table summarizes operating results for the two years indicated.
The increase in operating loss was primarily driven by aforementioned decreases in pounds shipped and lower selling price 16 Table of Contents The following tables summarize operating results for the two years indicated.
The increase in operating income was primarily driven by improved strategic sourcing initiatives and product line management resulting in lower raw material costs. The following tables summarize operating results for the two years indicated.
Results of Operations Comparison of 2023 to 2022 – Consolidated Consolidated net sales for the full-year 2023 decreased $68.8 million, or 26.3%, over the full-year 2022 to $193.2 million. The decrease in net sales was primarily driven by a 8.5% decrease in average price coupled with a 18.7% decrease in pounds shipped.
The decrease in net sales was primarily driven by an 8.8% decrease in average selling prices coupled with a 0.9% decrease in pounds shipped. Full-year 2024 gross profit from continuing operations increased 1349.1% to $22.1 million, or 12.4% of sales, compared to $1.5 million, or 0.8% of sales, in the full-year 2023.
Consolidated selling, general and administrative expense (SG&A) for the full-year 2023 decreased $0.9 million to $26.7 million compared to $27.6 million for the full-year 2022. SG&A as a percentage of sales was 13.8% of sales for 2023 and 10.6% of sales for 2022.
The increase in dollars and percentage of sales for the full-year 2024 were primarily driven by improved strategic sourcing initiatives and product line management resulting in lower raw material costs. Selling, general and administrative expense (SG&A) from continuing operations for the full-year 2024 decreased $0.1 million to $26.6 million compared to $26.7 million for the full-year 2023.
The full-year decrease resulted primarily from decreases in salaries, wages and benefit, stock-based compensation, incentive bonuses due to lower attainment of performance goals, as well as decreases in other corporate overhead. The decreases were partially offset by increases in professional fees related to accounting, tax and other advisory related costs, taxes and licenses and insurance expenses.
The full-year decrease resulted primarily from allocating corporate expense to locations and decreases in stock compensation expense partially offset by increases in incentive bonus, professional fees, taxes and license expense and insurance expense. Interest expense was $0.3 million and $4.2 million for the full-years of 2024 and 2023, respectively.
As of December 31, 2023, the Company was in compliance with all financial debt covenants. See Note 6 in the notes to the consolidated financial statements for additional information on the Company's line of credit. Stock Repurchases and Dividends We may repurchase common stock and pay dividends from time to time pursuant to programs approved by our Board of Directors.
Stock Repurchases and Dividends We may repurchase common stock and pay dividends from time to time pursuant to programs approved by our Board of Directors. The payment of cash dividends is also subject to customary legal and contractual restrictions.
The discussion and analysis of our results of operations refers to continuing operations only unless noted. Consolidated net sales decreased 26.3%, or $68.8 million, compared to 2022 driven by decreases in average selling price and pounds shipped. Consolidated net loss increased to $34.2 million in 2023, compared to net income of $17.6 million in 2022.
The discussion and analysis of our results of operations refers to continuing operations unless noted. 14 Table of Contents Results of Operations Comparison of 2024 to 2023 – Continuing Operations Net sales from continuing operations for the full-year 2024 decreased $15.3 million, or 7.9%, over the full-year 2023 to $177.9 million.